Fatigue, Health and Mortality from age 70-100

Abstract Fatigue is common with aging, yet poorly described. We examined the prevalence, health and functional status, and mortality associated with fatigue between ages 70-100. The Jerusalem Longitudinal Study (1990-2021) prospectively followed a community-dwelling cohort born 1920-21, at ages 70, 78, 85, 90, 95 and 100 (n = 604, 1024, 1222, 729, 508, 205 respectively). Comprehensive assessment included fatigue (“Do you feel generally tired?”) and mortality data. Logistic regression models (adjusted for gender, education, self-rated health [SRH], Charlson comorbidity index [CCI], ADL, depression, chronic musculoskeletal pain), Kaplan-Meier survival curves, and Cox proportional hazards models (adjusted for gender, education, CCI) were performed. At ages 70, 78, 85, 90, 95, 100 the prevalence of fatigue was 29.4%, 52.3%, 67.9%, 77.2%, 64.9%, and 65.6%. Between age 70-100, fatigue was significantly associated with numerous cross-sectional health and functional measures, and subsequent deterioration for loneliness, SRH, ADL dependence, and physical activity. In contrast, no consistent pattern of association with current or subsequent common medical morbidities was observed. Significantly decreased survival rates were observed among fatigued vs. non-fatigued subjects at ages 70-78, 78-85, 85-90, 90-95: 69.6% vs 80.8% (p = 0.0078), 64.9% vs 73.3% (p = 0.0016), 60.6% vs 76.4% (p < 0.0001), 51.3% vs 65.0% (p = 0.0068) respectively, yet not 95-100: 21.7% vs 18.8% (p = 0.99). After adjusting for known mortality risk factors, fatigue at age 70, 85 and 90 was associated with increased mortality. Fatigue is increasingly common with advancing age, and demonstrates significant negative impact upon health and survival. The poor association with medical morbidities raises questions concerning possible pathways of action.

Authors

Institutions

Publication Details

Journal
Innovation in Aging
Published
2025-12-01
DOI
https://doi.org/10.1093/geroni/igaf122.163
Primary Topic
Fibromyalgia and Chronic Fatigue Syndrome Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fatigue, Health and Mortality from age 70-100

ALIZA ROZENBERG, Jeremy M. Jacobs, Jochanan Stessman, Irit Stessman-Lande
Innovation in Aging
Fibromyalgia and Chronic Fatigue Syndrome Research
article

Fatigue, Health and Mortality from age 70-100

ALIZA ROZENBERG, Jeremy M. Jacobs, Jochanan Stessman, Irit Stessman-Lande
article en

Abstract

Abstract Fatigue is common with aging, yet poorly described. We examined the prevalence, health and functional status, and mortality associated with fatigue between ages 70-100. The Jerusalem Longitudinal Study (1990-2021) prospectively followed a community-dwelling cohort born 1920-21, at ages 70, 78, 85, 90, 95 and 100 (n = 604, 1024, 1222, 729, 508, 205 respectively). Comprehensive assessment included fatigue (“Do you feel generally tired?”) and mortality data. Logistic regression models (adjusted for gender, education, self-rated health [SRH], Charlson comorbidity index [CCI], ADL, depression, chronic musculoskeletal pain), Kaplan-Meier survival curves, and Cox proportional hazards models (adjusted for gender, education, CCI) were performed. At ages 70, 78, 85, 90, 95, 100 the prevalence of fatigue was 29.4%, 52.3%, 67.9%, 77.2%, 64.9%, and 65.6%. Between age 70-100, fatigue was significantly associated with numerous cross-sectional health and functional measures, and subsequent deterioration for loneliness, SRH, ADL dependence, and physical activity. In contrast, no consistent pattern of association with current or subsequent common medical morbidities was observed. Significantly decreased survival rates were observed among fatigued vs. non-fatigued subjects at ages 70-78, 78-85, 85-90, 90-95: 69.6% vs 80.8% (p = 0.0078), 64.9% vs 73.3% (p = 0.0016), 60.6% vs 76.4% (p < 0.0001), 51.3% vs 65.0% (p = 0.0068) respectively, yet not 95-100: 21.7% vs 18.8% (p = 0.99). After adjusting for known mortality risk factors, fatigue at age 70, 85 and 90 was associated with increased mortality. Fatigue is increasingly common with advancing age, and demonstrates significant negative impact upon health and survival. The poor association with medical morbidities raises questions concerning possible pathways of action.

Innovation in AgingVol. 9(Supplement_2)
Hebrew University of Jerusalem (IL), Hadassah Medical Center (IL)
Good health and well-being
Openalex Percentile: Top 30%
Fibromyalgia and Chronic Fatigue Syndrome Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Fatigue, Health and Mortality from age 70-100 — ALIZA ROZENBERG, Jeremy M. Jacobs, et al. · Innovation in Aging (2025) | TGRS Research Map | TGRS